clinical usefulness of M2BPGi for detecting patients with liver disease progression

clinical usefulness of M2BPGi for detecting patients with liver disease progression - clinical usefulness of M2BPGi for detecting patients with liver disease progression

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043904

Enrollment

3900

Registered

2021-04-15

Start date

2021-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver dysfunction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Nagawa Town Citizens' Dock and Specific Medical Examination (biennial) examinees and members of the Japan Health Insurance Association, etc.

Exclusion criteria

Exclusion criteria: Residents who did not consent to this research test. Patients who have already been diagnosed with viral hepatitis and have started treatment. Patients who cannot receive medical examinations because they require nursing care 3 or more

Design outcomes

Primary

Measure	Time frame
Clarify the clinical significance of M2BPGi in efficient liver disease pick-up and motivation for consultation.	—

Countries

Japan

Contacts

Public ContactSatoru Joshita

Shinshu University School of Medicine Department of Medicine, Division of Gastroenterology and Hepatology

ninai@shinshu-u.ac.jp0263-37-2634

Outcome results